Amarin Corporation’s Third Quarter 2024 Results
Oct 30, 2024 5:00 PM EDT
About Amarin
About Amarin
Amarin is an innovative global pharmaceutical company committed to providing cost-effective cardiovascular care to high-risk adult cardiovascular patients.Find out more.
Our Science
Our Science
We use innovative science and research methods to develop new, cost-effective treatments for cardiovascular disease. Discover more about our methodology, trials and CV Health from Amarin.
Investor Relations
Investor Relations
Amarin strives to ensure that our stakeholders have access to appropriate information about our financial growth. Find out more to help you make an independent decision on your investments.
Event Details
ALL-NP-00022 1/23
©2026 Amarin Pharmaceuticals Ireland Limited.All rights reserved.
AMARIN, VASCEPA, VAZKEPA and REDUCE-IT names and logos are trademarks of Amarin Pharmaceuticals Ireland Limited. | ALL-NP-00014 1/23
